State Street’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $59.3M | Buy |
|
|||||
|
2025
Q2 | $32.2M | Sell |
|
|||||
|
2025
Q1 | $48.8M | Buy |
|
|||||
|
2024
Q4 | $51.8M | Buy |
|
|||||
|
2024
Q3 | $72.6M | Buy |
|
|||||
|
2024
Q2 | $74.4M | Sell |
|
|||||
|
2024
Q1 | $115M | Sell |
|
|||||
|
2023
Q4 | $108M | Buy |
|
|||||
|
2023
Q3 | $52.3M | Sell |
|
|||||
|
2023
Q2 | $86.9M | Buy |
|
|||||
|
2023
Q1 | $81.7M | Buy |
|
|||||
|
2022
Q4 | $92.9M | Buy |
|
|||||
|
2022
Q3 | $62.9M | Buy |
|
|||||
|
2022
Q2 | $46.9M | Buy |
|
|||||
|
2022
Q1 | $41.4M | Sell |
|
|||||
|
2021
Q4 | $54.3M | Buy |
|
|||||
|
2021
Q3 | $40.2M | Sell |
|
|||||
|
2021
Q2 | $54.4M | Buy |
|
|||||
|
2021
Q1 | $59.3M | Buy |
|
|||||
|
2020
Q4 | $37.8M | Buy |
|
|||||
|
2020
Q3 | $16.5M | Buy |
|
|||||
|
2020
Q2 | $7.01M | Buy |
|
|||||
|
2020
Q1 | $4.83M | Sell |
|
|||||
|
2019
Q4 | $3.87M | Buy |
|
|||||
|
2019
Q3 | $3.1M | Buy |
|
|||||
|
2019
Q2 | $3.02M | Buy |
|
|||||
|
2019
Q1 | $1.27M | Buy |
|
|||||
|
2018
Q4 | $973K | Buy |
|
|||||
|
2018
Q3 | $1.58M | Buy |
|
|||||
|
2018
Q2 | $1.08M | Buy |
|
|||||
|
2018
Q1 | $1.85M | Buy |
|
|||||
|
2017
Q4 | $1.02M | Buy |
|
|||||
|
2017
Q3 | $991K | Buy |
|
|||||
|
2017
Q2 | $1.14M | Buy |
|
|||||
|
2017
Q1 | $841K | Buy |
|
|||||
|
2016
Q4 | $422K | Buy |
|
|||||
|
2016
Q3 | $840K | Buy |
|
|||||
|
2016
Q2 | $448K | Buy |
|